GLP-1 & Longevity in Midlife: It's About More Than Weight Loss
For most people, GLP-1 medications are synonymous with one thing: weight loss.
That's what dominates the headlines. Social media is filled with before-and-after photos. Celebrities are talking about them. News stories focus on how much weight people are losing.
But here's the thing.
Weight loss isn't why GLP-1 medications were created.
And for women in perimenopause and menopause, I believe focusing only on weight loss causes us to miss the much bigger story.
Emerging research suggests these medications may support metabolic health, cardiovascular health, blood sugar regulation, kidney health, and other factors that influence healthy aging and longevity.
That's a conversation worth having.
GLP-1 Medications Were Originally Developed for Type 2 Diabetes
GLP-1 itself was discovered in the 1980s. The first medication in this class was approved in 2005 to help manage type 2 diabetes.
The goal wasn't weight loss.
These medications were designed to help the body release insulin when it's needed, reduce the amount of glucose released by the liver, and slow stomach emptying to improve blood sugar regulation.
Weight loss didn't become part of the conversation until 2021, when semaglutide was approved for chronic weight management.
From that point on, GLP-1 medications quickly became known as "weight loss drugs."
While weight loss is certainly one benefit, it's only one piece of a much larger picture.
Why This Matters So Much During Perimenopause and Menopause
As estrogen declines, our bodies change in ways that affect far more than our waistline.
Many women begin to experience:
Increased insulin resistance
Higher fasting blood sugar and A1c
Rising blood pressure
Changes in cholesterol
More visceral (abdominal) fat
Increased inflammation
A higher risk of cardiovascular disease
A greater likelihood of fatty liver disease and sleep apnea
Most of these changes happen quietly.
You may not notice them right away, and the scale doesn't always reflect what's happening inside your body.
That's why researchers have become increasingly interested in the health benefits of GLP-1 medications beyond weight loss.
GLP-1 Medications and Heart Health
Heart disease is the leading cause of death in women.
Not breast cancer.
Heart disease.
One reason our cardiovascular risk increases after menopause is that estrogen has spent decades helping protect our blood vessels. As estrogen declines, blood vessels become less flexible, inflammation increases, blood pressure often rises, and cholesterol patterns begin to change.
One of the most significant studies on GLP-1 medications, the SELECT trial, found that semaglutide reduced the risk of major cardiovascular events—including heart attack, stroke, and cardiovascular death—by 20% in adults with overweight or obesity and established cardiovascular disease.
That's much bigger than a weight loss benefit.
It's a heart health benefit.
Better Blood Sugar Control in Midlife
Blood sugar has always been personal for me because I developed gestational diabetes during both of my pregnancies.
I've watched my blood sugar closely for years.
Many women notice that during perimenopause, foods they've eaten for decades suddenly affect them differently. Their fasting glucose starts creeping upward. Their A1c increases. They hear the word "prediabetes" for the first time and wonder what changed.
Much of the answer comes back to estrogen.
Estrogen helps our cells respond to insulin. As estrogen declines, insulin resistance becomes more common, meaning the body has to work harder to regulate blood sugar.
That contributes to higher blood sugar, increased abdominal fat, stronger cravings, and the frustrating difficulty losing weight that so many women experience.
GLP-1 medications improve blood sugar regulation and may help reduce progression toward type 2 diabetes.
That's about protecting your long-term metabolic health—not just losing weight.
Kidney Health Is Part of the Conversation Too
Kidney health may not seem like a menopause topic, but it should be.
The two biggest causes of chronic kidney disease are diabetes and high blood pressure, both of which become more common after menopause.
Clinical studies suggest GLP-1 medications may help slow the progression of chronic kidney disease, particularly in people living with type 2 diabetes.
Researchers believe this may be due to better blood sugar control, lower blood pressure, and possibly direct protective effects on the kidneys themselves.
As women's metabolic health changes during midlife, that's another potential benefit worth paying attention to.
Sleep Apnea Becomes More Common After Menopause
Many people associate sleep apnea with overweight men.
The reality is that women's risk increases significantly after menopause.
Hormonal changes affect breathing during sleep, while changes in body fat distribution can further increase the risk.
Poor sleep doesn't just leave you exhausted.
It can increase blood pressure, worsen insulin resistance, raise cardiovascular risk, and affect cognitive health.
Newer GLP-1 and GLP-1/GIP medications have shown meaningful improvements in people with obesity-related obstructive sleep apnea.
Again, that's a benefit that extends beyond the number on the scale.
GLP-1 Medications May Support Liver Health
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, is becoming increasingly common.
As insulin resistance worsens during perimenopause and menopause, the risk of developing MASLD also increases.
Most people don't realize they have it because there are often no symptoms.
Research continues to show that GLP-1 medications may reduce liver fat and improve markers of liver inflammation, making this another exciting area of metabolic health research.
The Future of GLP-1 Research
Researchers are continuing to study GLP-1 medications for a variety of health conditions beyond diabetes and weight management.
Current areas of research include:
Chronic inflammation
Osteoarthritis
Alcohol use disorder and addiction
Alzheimer's disease
Parkinson's disease
Other neurodegenerative conditions
These are not approved uses, and much more research is needed before conclusions can be drawn.
Still, it's fascinating that scientists are asking these questions. It suggests GLP-1 medications may influence many aspects of health beyond appetite regulation.
Longevity Is About More Than Living Longer
When I think about longevity, I don't just think about adding years to life.
I think about adding life to those years.
I want to maintain muscle.
I want healthy blood sugar.
I want to lower my risk of heart disease.
I want energy to travel, spend time with my family, stay active, and continue doing the work I love.
For many women, that's the real goal.
Weight loss may be part of the journey, but it isn't the destination.
The Bottom Line
I don't believe we should think of GLP-1 medications as simply "weight loss drugs" anymore.
The emerging research tells a much bigger story.
For women in perimenopause and menopause, these medications may support heart health, metabolic health, blood sugar regulation, kidney health, liver health, and other factors that influence healthy aging and longevity.
Of course, the medication isn't the whole picture.
Nutrition still matters.
Strength training still matters.
Sleep still matters.
Stress management still matters.
GLP-1 medications are a tool—not a replacement for the habits that build long-term health.
When those pieces work together, that's where the real opportunity lies.
And that's why I believe it's time we started talking about GLP-1 medications as more than a weight loss treatment.
They're becoming part of a much bigger conversation about helping women stay healthier, stronger, and more resilient through one of the biggest hormonal transitions of their lives.
Frequently Asked Questions
Are GLP-1 medications only for weight loss?
No. GLP-1 medications were originally developed to help manage type 2 diabetes. While many people lose weight on these medications, researchers continue to discover benefits related to blood sugar regulation, cardiovascular health, kidney health, and other aspects of metabolic health.
Can GLP-1 medications improve longevity?
No medication has been proven to increase lifespan directly. However, GLP-1 medications have been shown to improve several factors associated with healthy aging, including blood sugar control and cardiovascular health. Researchers are also studying their potential role in other chronic diseases that affect long-term health.
Are GLP-1 medications right for every woman in menopause?
Not necessarily. Whether a GLP-1 medication is appropriate depends on your medical history, health goals, and guidance from your licensed healthcare provider. These medications are one tool that may support health, but they work best alongside proper nutrition, resistance training, quality sleep, and stress management.
